Cargando…
Effect of the COVID-19 Pandemic Lockdown on the Management of Diabetic Retinopathy: A Cross-Sectional Study
Introduction Worldwide, diabetic retinopathy (DR) is one of the leading causes of vision loss. Early treatment and screening for DR have a major role in reducing the rate of the disease and the coronavirus disease 2019 (COVID-19) pandemic-related restrictions have altered real-world practice pattern...
Autores principales: | Prajapati, Vaishali, Shah, Krishna, Shah, Dhruvi, Wanjari, Mayur B, Singhal, Deepika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436826/ https://www.ncbi.nlm.nih.gov/pubmed/36072193 http://dx.doi.org/10.7759/cureus.27623 |
Ejemplares similares
-
Effect of COVID-19-Associated Lockdown on Patients With Diabetic Retinopathy
por: Chatziralli, Irini, et al.
Publicado: (2021) -
Prevalence and Risk Factors of Retinopathy in Type 1 Diabetes: A Cross-Sectional Study
por: Berrabeh, Soumiya, et al.
Publicado: (2023) -
Physical Activity Status and Diabetic Retinopathy: A Review
por: AlQabandi, Yousif, et al.
Publicado: (2022) -
Surprising Diagnosis of Myxedema Crisis In-Patient Who Presented With Altered Sensorium
por: Umalkar, Gajanan N, et al.
Publicado: (2023) -
Management of Obese Type 1 Diabetes Mellitus (Double Diabetes) Through Telemedicine During COVID-19 Pandemic Lockdown: A Case Report
por: Gupta, Swar, et al.
Publicado: (2022)